FDA — authorised 7 June 1971
- Marketing authorisation holder: NOVARTIS
- Status: approved
🇺🇸 Naphcon Forte in United States
FDA authorised Naphcon Forte on 7 June 1971
Marketing authorisations
FDA — authorised 6 March 1974
- Application: ANDA080229
- Marketing authorisation holder: ALCON
- Local brand name: NAPHCON FORTE
- Indication: SOLUTION/DROPS — OPHTHALMIC
- Status: approved
Naphcon Forte in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Ophthalmology approved in United States
Frequently asked questions
Is Naphcon Forte approved in United States?
Yes. FDA authorised it on 7 June 1971; FDA authorised it on 6 March 1974.
Who is the marketing authorisation holder for Naphcon Forte in United States?
NOVARTIS holds the US marketing authorisation.